Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

teva pharma b.v., utrecht, the netherlands - brimonidine tartrate, timolol maleate - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0,2%+0,5% - ineof01093 - brimonidine tartrate - 2.000000 mg; 0025839752 - timolol maleate - 6.800000 mg - timolol, combinations

Canada - engelsk - Health Canada

micro labs limited - timolol (timolol maleate); dorzolamide (dorzolamide hydrochloride) - solution - 5mg; 20mg - timolol (timolol maleate) 5mg; dorzolamide (dorzolamide hydrochloride) 20mg

Canada - fransk - Health Canada

micro labs limited - timolol (maléate de timolol); dorzolamide (chlorhydrate de dorzolamide) - solution - 5mg; 20mg - timolol (maléate de timolol) 5mg; dorzolamide (chlorhydrate de dorzolamide) 20mg

USA - engelsk - NLM (National Library of Medicine)

akorn - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride-timolol maleate is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of dorzolamide hydrochloride-timolol maleate administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies (14)]. dorzolamide hydrochloride-timolol maleate is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions (5.1)] . dorzolamide hydrochloride-timolol maleate is contraindicated in patients with sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, and cardiogenic shock [see warnings and precautions (5.2)] . do

Canada - engelsk - Health Canada

alcon canada inc - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 2.0%; 0.5% - dorzolamide (dorzolamide hydrochloride) 2.0%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

USA - engelsk - NLM (National Library of Medicine)

armas pharmaceuticals inc - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5% is an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (iop) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop; the iop-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. brimonidine tartrate/timolol maleate ophthalmic solution is contraindicated in patients with reactive airway disease including bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease [see warnings and precautions ( 5.1, 5.3)] . brimonidine tartrate/timolol maleate ophthalmic solution is contraindicated in patients with s

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - tartrate de brimonidine 2 mg/ml - eq. brimonidine 1,3 mg/ml; maléate de timolol 6,8 mg/ml - eq. timolol 5 mg/ml - collyre en solution - 2 mg/ml - 5 mg/ml - tartrate de brimonidine 2 mg/ml; maléate de timolol 6.8 mg/ml - timolol

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; sodium hydroxide; dibasic sodium phosphate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - timololmaleaat 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 0,05 mg/ml - oogdruppels, oplossing - 50 µg/ml - 5 mg/ml - latanoprost 0.05 mg/ml; timololmaleaat 6.83 mg/ml - timolol, combinations

Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - timololmaleaat 6,83 mg/ml - eq. timolol 5 mg/ml; travoprost 0,04 mg/ml - oogdruppels, oplossing - 40 µg/ml - 5 mg/ml - travoprost 0.04 mg/ml; timololmaleaat 6.83 mg/ml - timolol, combinations